Hepatobiliary research
显示 65-78 个结果（共 78 个结果）
-
Sofosbuvir Tablets (Dongyangguang) – 400mg × 28 Tablets
Dongyangguang Sofosbuvir Tablets deliver 400?mg per tablet, with 28 tablets per box (4 blisters of 7). Manufactured by Yichang Dongyangguang Changjiang Pharmaceuticals under Chinese approval H20233865 . Ideal for preclinical hepatitis C virus (HCV) research focusing on viral replication, resistance, and antiviral screening. ?? For laboratory and research use only.?Please consult staff for other specifications and uses? $2.00 -
Sofosbuvir Tablets (Sovaldi) – 400?mg Low price comparison
Sovaldi (sofosbuvir) delivers 400?mg per orange film?coated tablet, 28 tablets per bottle. Manufactured by Gilead Sciences Ireland UC, approved in China under HJ20170365, this potent NS5B polymerase inhibitor is widely used in research on hepatitis C virus replication mechanisms, antiviral screening, and resistance studies.
?? For laboratory and research use only. Not for clinical or diagnostic applications.?Please consult staff for other specifications and uses? $1.00 -
Sofosbuvir Tablets – Sibowe 400?mg × 28 Tablets
Sibowe Sofosbuvir Tablets provide 400?mg per tablet, 28 tablets per package (4 × 7?tablet blisters). Manufactured by Beijing Kain Gene Biotechnology Co., Ltd. and approved by NMPA under H20203108 . Ideal for hepatitis C virus (HCV) replication and antiviral mechanism studies.
?? For laboratory and research use only. Not for clinical or diagnostic use.?Please consult staff for other specifications and uses? $1.00 -
Telmisartan Tablets (Yabang Hengbei) – 40?mg
Yabang Hengbei Telmisartan Tablets, 40?mg each in a box of 7, are ARB compounds widely used in preclinical studies on hypertension, heart, and kidney protection. For laboratory research use only; not for clinical application.?Please consult staff for other specifications and uses? $1.20 -
Telmisartan Tablets (Yabang Hengbei) – 40?mg Low Price Wholesale Comparison
Yabang Hengbei Telmisartan Tablets contain 40?mg of the angiotensin?II receptor blocker per tablet, packaged in a 28-tablet box. Manufactured by Jiangsu Yabang Epsom Pharma, approved under NMPA H20041522. Ideal for hypertension, heart, and kidney preclinical studies.
?? For laboratory research only ?Please consult staff for other specifications and uses? $2.00 -
Tenofovir Alafenamide Fumarate Tablets (Meiganneng) – 25?mg × 30 Tablets
Meiganneng Tenofovir Alafenamide Fumarate (TAF) tablets provide 25?mg per tablet, 30 tablets per bottle. Manufactured by Hunan Mingrui Pharmaceutical Co., Ltd., approved under H20213856. TAF is a liver-targeting nucleotide analog prodrug used in preclinical research for hepatitis B and HIV models, offering improved safety vs. older tenofovir forms.
?? For laboratory and research use only. Not for clinical applications.?Please consult staff for other specifications and uses? $2.00 -
Tenofovir Alafenamide Fumarate Tablets 25?mg (Zhongyan) – Low price wholesale
Zhongyan Tenofovir Alafenamide Fumarate Tablets contain 25?mg of active drug per tablet in a bottle of 30 tablets. Manufactured by Tianjin Institute of Pharmaceutical Research and approved under NMPA H20233581. Ideal for use in hepatitis B research, viral suppression studies, and pharmacokinetic analysis.
?? For laboratory and research use only. ?Please consult staff for other specifications and uses? $2.00 -
Tenofovir Amibufenamide Tablets 25?mg Low price wholesale
Tenofovir Amibufenamide Tablets (Hengmu) contain 25?mg of tenofovir amibufenamide per film-coated tablet, packaged 28 tablets per box. Manufactured by Changzhou Hengbang Pharmaceutical Co., Ltd. (China). Approved under NMPA H20210029, this product is intended strictly for laboratory use in chronic hepatitis B (CHB) studies, viral replication inhibition, and pharmacokinetics modeling.
?? For research purposes only.?Please consult staff for other specifications and uses?
$2.00 -
Thymalfasin Injection (Jitai) – 1.6?mg × 2 Vials
Jitai Thymalfasin injection provides 1.6?mg of synthetic thymosin??1 per vial, with 2 vials per box. Manufactured by Hainan Shuancheng Pharmaceutical Co., Ltd. under NMPA approval H20030407, this peptide is used in experimental models of chronic hepatitis B, C, immunosuppression, cancer immunotherapy, sepsis, and vaccine adjuvancy.
?? For laboratory and research use only. Not for clinical or diagnostic use.?Please consult staff for other specifications and uses? $1.00 -
Thymalfasin Injection 1.6?mg (Harbin/Thymosin ??1) – Wholesale price comparison
Harbin Thymalfasin Injection contains 1.6?mg of Thymosin ??1 per vial with included solvent. Manufactured by Harbin Pharmaceutical Group Bioengineering Co., Ltd., and approved under NMPA H20133153. Commonly used for preclinical research in immune modulation, antiviral response, and vaccine adjuvant studies.
?? For laboratory research use only.?Please consult staff for other specifications and uses? $2.00 -
Tiopronin Sodium 0.1?g ×?5 Vials (Xingpuning) Low Price Wholesale Comparison
Xingpuning Tiopronin Injection provides 100?mg tiopronin sodium per vial, with 5 vials per box. Manufactured by Guangdong Xinghao Pharmaceutical Co., Ltd., approved under NMPA H20198007. Primarily used in lab models of cystine stone prevention, heavy metal detoxification, liver protection, and oxidative stress assays.
?? For laboratory and research use only. ?Please consult staff for other specifications and uses? $2.00 -
Tiopronin Sodium Injection 0.1?g (Sulpronin) Low Price Wholesale Comparison
Sulpronin Injection provides 100?mg tiopronin sodium per vial, with 10 vials per box. Manufactured by Jincheng Haise Pharmaceutical Company and approved under NMPA H20067498. Often used in preclinical studies on acute/chronic hepatitis, fatty liver, drug-induced liver injury, heavy metal detoxification, and radiotherapy-induced toxicity.
?? For research use only.?Please consult staff for other specifications and uses? $1.00 -
Ursodeoxycholic Acid Capsules 250?mg (Youshian) – Low price wholesale
Youshian Ursodeoxycholic Acid Capsules contain 250?mg of ursodeoxycholic acid per capsule, 14 capsules per box. Manufactured by Ans Pharmaceutical (Zhongshan) Co., Ltd., with NMPA approval H20213697. Commonly used in research relating to gallstone treatment, cholestatic liver disorders, and bile acid modulation.
?? For laboratory and research use only. ?Please consult staff for other specifications and uses? $6.00 -
Ursodeoxycholic Acid Tablets (Bifu) – 0.25?g × 18 Tablets
Bifu Ursodeoxycholic Acid Tablets contain 250?mg of UDCA per tablet in an 18?tablet pack (three 6?count blisters). Produced by Wuhan Puyuan Pharmaceutical Co., Ltd., under NMPA approval H20123209, this bile acid compound is commonly used in lab models for hepatoprotection, cholestasis, gallstone dissolution, and cholesterol metabolism studies. ?? Strictly for laboratory and research use only.?Please consult staff for other specifications and uses? $1.00
